Skip to content

A trial comparing conventional fractionation with 'CHART' in the radical treatment of non-small cell carcinoma of the bronchus

A trial comparing conventional fractionation with 'CHART' in the radical treatment of non-small cell carcinoma of the bronchus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74298211
Enrollment
600
Registered
2001-02-28
Start date
1990-02-01
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Non-small cell carcinoma of the bronchus

Interventions

1. Conventional radiotherapy arm - 2 Gy, once daily five days a week over six weeks (large volume - 44 Gy in 22 fractions followed by small volume - 16 Gy in eight fractions) 2. CHART

Sponsors

Medical Research Council (MRC) (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inoperable non-small cell carcinoma of the bronchus confined to the thorax proven by histology or by unequivocal brush cytology

Exclusion criteria

Exclusion criteria: 1. There should be no evidence of distant metastases including supraclavicular nodes; 2. The patient must have no evidence of a pleural effusion unless it can be attributed to a recent surgical intervention; 3. The volume of the site of tumour within the thorax should be such that a radical course of radiotherapy could be given without prejudicing vital structures such as the spinal cord or lung

Design outcomes

Primary

MeasureTime frame
Survival, Local tumour control, Morbidity

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026